/5
0 avis
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk. Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk: Update on PCSK9 inhibitors and lipoprotein (a)
Archive ouverte
Edité par CCSD ; Lippincott, Williams & Wilkins -
International audience
Consulter en ligne
Chargement des enrichissements...